Fluticasone furoate
- Generic Name
- Fluticasone furoate
- Brand Names
- Arnuity Ellipta, Avamys, Breo Ellipta, Flonase Sensimist, Trelegy Ellipta, Veramyst
- Drug Type
- Small Molecule
- Chemical Formula
- C27H29F3O6S
- CAS Number
- 397864-44-7
- Unique Ingredient Identifier
- JS86977WNV
- Background
Fluticasone furoate is a synthetic glucocorticoid available as an inhaler and nasal spray for various inflammatory indications. Fluticasone furoate was first approved in 2007.
- Indication
Fluticasone furoate is indicated for once-daily maintenance (i.e. prophylactic) treatment of asthma in patients ≥5 years old. Fluticasone furoate is available in two combination medications - one in combination with vilanterol and one in combination with both vilanterol and umeclidinium- which are both indicated for the management of chronic obstructive pulm...
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Perennial Allergy, Seasonal Allergies
- Associated Therapies
- -
Rhinitis, Cognition and Driving Performance
- Conditions
- Interventions
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- Maastricht University Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT01318681
- Locations
- 🇳🇱
Maastricht University, Maastricht, Limburg, Netherlands
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
- Conditions
- Interventions
- First Posted Date
- 2011-03-14
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 16568
- Registration Number
- NCT01313676
- Locations
- 🇻🇳
GSK Investigational Site, Hue, Vietnam
Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 16
- Registration Number
- NCT01299558
- Locations
- 🇦🇺
GSK Investigational Site, Randwick, New South Wales, Australia
A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
- Conditions
- Interventions
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 540
- Registration Number
- NCT01199757
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
- Conditions
- Interventions
- First Posted Date
- 2010-07-12
- Last Posted Date
- 2017-11-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 350
- Registration Number
- NCT01159912
- Locations
- 🇷🇴
GSK Investigational Site, Iasi, Romania
Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response
- Conditions
- Interventions
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 27
- Registration Number
- NCT01128595
- Locations
- 🇸🇪
GSK Investigational Site, Lund, Sweden
Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response
- Conditions
- Interventions
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 52
- Registration Number
- NCT01128569
- Locations
- 🇬🇧
GSK Investigational Site, Manchester, United Kingdom
Asthma Exacerbation Study
- Conditions
- Interventions
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 2020
- Registration Number
- NCT01086384
- Locations
- 🇺🇦
GSK Investigational Site, Zaporizhia, Ukraine
Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease
- Conditions
- Interventions
- First Posted Date
- 2009-11-16
- Last Posted Date
- 2017-09-13
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 7
- Registration Number
- NCT01013701
Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2017-06-22
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 80
- Registration Number
- NCT01000597
- Locations
- 🇦🇺
GSK Investigational Site, Randwick, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.